TNSN00178A1 - Fused pyrrolecaboxamides; a new class of gaba brain receptor ligands - Google Patents
Fused pyrrolecaboxamides; a new class of gaba brain receptor ligandsInfo
- Publication number
- TNSN00178A1 TNSN00178A1 TNTNSN00178A TNSN00178A TNSN00178A1 TN SN00178 A1 TNSN00178 A1 TN SN00178A1 TN TNSN00178 A TNTNSN00178 A TN TNSN00178A TN SN00178 A TNSN00178 A TN SN00178A TN SN00178 A1 TNSN00178 A1 TN SN00178A1
- Authority
- TN
- Tunisia
- Prior art keywords
- gaba
- pyrrolecaboxamides
- fused
- compounds
- new class
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SUBSTITUED PYRROLECARBOXAMIDE COMPOUNDS ARE DISCLOSED. THESE COMPOUNDS ARE HIGHLY SELECTIVE AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GABA BRAIN RECEPTORS OR PRODRUGS OF AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GABA BRAIN RECEPTORS AND ARE THEREFORE USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, ALZHEIMER'S DEMENTIA, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND FOR ENHANCEMENT OF MEMORY. PHARMACEUTICAL COMPOSITIONS, INCLUDING PACKAGED PHARMACEUTICAL COMPOSITIONS, ARE FURTHER PROVIDED. COMPOUNDS OF THE INVENTION ARE ALSO USEFUL AS PROBES FOR THE LOCALIZATION OF GABA RECEPTORS IN TISSUE SAMPLES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38731199A | 1999-08-31 | 1999-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN00178A1 true TNSN00178A1 (en) | 2002-05-30 |
Family
ID=27805344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN00178A TNSN00178A1 (en) | 1999-08-31 | 2000-08-30 | Fused pyrrolecaboxamides; a new class of gaba brain receptor ligands |
Country Status (10)
Country | Link |
---|---|
AR (1) | AR040397A1 (en) |
CO (1) | CO5180633A1 (en) |
EC (1) | ECSP003641A (en) |
GT (1) | GT200000146A (en) |
PA (1) | PA8501901A1 (en) |
PE (1) | PE20010533A1 (en) |
SV (1) | SV2002000161A (en) |
TN (1) | TNSN00178A1 (en) |
UY (1) | UY26322A1 (en) |
ZA (1) | ZA200201649B (en) |
-
2000
- 2000-08-30 TN TNTNSN00178A patent/TNSN00178A1/en unknown
- 2000-08-31 SV SV2000000161A patent/SV2002000161A/en unknown
- 2000-08-31 AR ARP000104564 patent/AR040397A1/en not_active Application Discontinuation
- 2000-08-31 UY UY26322A patent/UY26322A1/en not_active Application Discontinuation
- 2000-08-31 PE PE2000000891A patent/PE20010533A1/en not_active Application Discontinuation
- 2000-08-31 EC ECSP003641 patent/ECSP003641A/en unknown
- 2000-08-31 CO CO00065554A patent/CO5180633A1/en unknown
- 2000-08-31 GT GT200000146A patent/GT200000146A/en unknown
- 2000-08-31 PA PA8501901A patent/PA8501901A1/en unknown
-
2002
- 2002-02-27 ZA ZA200201649A patent/ZA200201649B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PE20010533A1 (en) | 2001-05-01 |
PA8501901A1 (en) | 2002-12-11 |
SV2002000161A (en) | 2002-09-04 |
AR040397A1 (en) | 2005-04-06 |
ECSP003641A (en) | 2002-03-25 |
ZA200201649B (en) | 2003-05-28 |
CO5180633A1 (en) | 2002-07-30 |
UY26322A1 (en) | 2001-06-29 |
GT200000146A (en) | 2002-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4818000A (en) | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands | |
AU2001285451A1 (en) | 2,4-substituted pyridine derivatives | |
WO1999063996A8 (en) | Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors | |
WO2002000623A3 (en) | Aryl fused substituted 4-oxy-pyridines | |
AP2002002420A0 (en) | Fused pyrrolecarboxamides: gaba brain receptor ligands. | |
IL146871A0 (en) | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases | |
FR13C0062I2 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR TREATING NEUROLOGICAL DISORDERS | |
ATE328609T1 (en) | COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE, WHICH CONTAIN ANTAGONISTS OF CB1 RECEPTORS AND ACTIVATION SUBSTANCES OF DOPAMINE NEUROTRANSMISSION IN THE BRAIN | |
MXPA03009644A (en) | 1 substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists). | |
DE69930308D1 (en) | SELECTIVE 5-HT 6 RECEPTOR LIGANDS | |
IL147977A0 (en) | Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain | |
HUP0202399A3 (en) | Use of dopamine d3 receptor ligands for producing pharmaceutical compositions for treating kidney disorders | |
NZ509762A (en) | 5-Azatricyclo[3.3.1.1<3,7>]decane derivatives, pharmaceuticals thereof, and their use as cholinergic receptor agonists and antagonists | |
WO2000012623A3 (en) | Use of 5-th receptor antagonists for the treatment of parkinson's disease | |
CA2333086A1 (en) | Cocaine receptor binding ligands | |
AU4058000A (en) | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors | |
SI1553985T1 (en) | Biphenyls as imaging agents in alzheimer's disease | |
BR0307504A (en) | Pharmaceutically acceptable compound or salt, pharmaceutical composition, methods for treating disease, for enhancing a therapeutic effect of a snc agent, for enhancing short-term memory in a patient, for determining the presence or absence of gabaa receptors in a sample, and to alter gabaa receptor signal transducer activity, packaging, and use of a compound or salt | |
TNSN00178A1 (en) | Fused pyrrolecaboxamides; a new class of gaba brain receptor ligands | |
GB0008321D0 (en) | Biological material and uses thereof | |
AU4536599A (en) | Metal-rich silica products from geothermal and synthetic aqueous systems nen wie | |
AU5691199A (en) | Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands | |
MY107732A (en) | Certain imidazoquinoxalines; a new class of gaba brain receptor ligands. |